Olle Ringden

Olle Ringden

UNVERIFIED PROFILE

Are you Olle Ringden?   Register this Author

Register author
Olle Ringden

Olle Ringden

Publications by authors named "Olle Ringden"

Are you Olle Ringden?   Register this Author

100Publications

3101Reads

18Profile Views

Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells.

Front Immunol 2019 19;10:2685. Epub 2019 Nov 19.

Translational Cell Therapy Research (TCR), Department of Clinical Science Intervention and Technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.02685DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877599PMC
November 2019

Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2019 Oct 4;25(10):1965-1969. Epub 2019 Jun 4.

Translational Cell Therapy Research, Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institute, Huddinge, Sweden.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791193035
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2019.05.034DOI Listing
October 2019

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant 2019 Oct 7;25(10):1975-1983. Epub 2019 Jun 7.

European Society for Blood and Marrow Transplantation, Paris study office/CEREST-TC, Paris, France; Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.05.037DOI Listing
October 2019

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Haematologica 2019 09 26. Epub 2019 Sep 26.

Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.220756DOI Listing
September 2019

Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation.

Acta Haematol 2018;139(2):106-114. Epub 2018 Feb 7.

Division of Translational Cell Therapy Research (TCR), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000485735DOI Listing
March 2019

Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines.

Trends Mol Med 2019 02 30;25(2):149-163. Epub 2019 Jan 30.

Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin (FUB), Humboldt-Universität zu Berlin (HUB), and Berlin Institute of Health (BIH), Berlin, Germany; Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin (FUB), Humboldt-Universität zu Berlin (HUB), and Berlin Institute of Health (BIH), Berlin, Germany; Berlin Center for Advanced Therapies (BECAT), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin (FUB), Humboldt-Universität zu Berlin (HUB), and Berlin Institute of Health (BIH), Berlin, Germany; Equal contribution senior authorship.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2018.12.006DOI Listing
February 2019

Photochemotherapy and Graft-versus-Leukemia Reaction in Acute Leukemia: Tumor Immunity and Survival Are Dependent on Timing of Photochemotherapy of the Skin.

Dermatology 2017 13;233(4):303-313. Epub 2017 Dec 13.

Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000484138DOI Listing
October 2018

Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.

Int J Hematol 2018 Apr 15;107(4):478-485. Epub 2017 Nov 15.

Department of LABMED, Translational Cell Therapy Research Group (TCR), Karolinska Institutet, Kliniskt Forskningscentrum (KFC), NOVUM Plan 6, Hälsovägen 7-9, 141 57, Huddinge, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-017-2363-5DOI Listing
April 2018

Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expression.

Nephrol Dial Transplant 2018 04;33(4):574-585

Clinic for Nephrology and Critical Care Medicine, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfx316DOI Listing
April 2018

Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?

Adv Exp Med Biol 2016 ;951:77-98

Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-45457-3_7DOI Listing
September 2017

Successful treatment with placenta-derived decidual stromal cells in a pediatric patient with life-threatening acute gastrointestinal graft-versus-host disease.

Pediatr Transplant 2017 Aug 13;21(5). Epub 2017 Jun 13.

Department of Women's and Children's Health, Pediatric Oncology, Children's University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/petr.12990DOI Listing
August 2017

Photochemotherapy of Cutaneous Graft-versus-Host Disease May Reduce Concomitant Visceral Disease.

Dermatology 2016 20;232(4):453-63. Epub 2016 Jul 20.

Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000447058DOI Listing
July 2017

Frontline Science: Placenta-derived decidual stromal cells alter IL-2R expression and signaling in alloantigen-activated T cells.

J Leukoc Biol 2017 03 20;101(3):623-632. Epub 2016 Sep 20.

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.5HI0616-284RDOI Listing
March 2017

A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer.

J Immunother 2017 Mar 23. Epub 2017 Mar 23.

*Division of Clinical Immunology and Transfusion Medicine ¶Center for Allogeneic Stem Cell Transplantation ∥Division of Therapeutic Immunology (TIM) Departments of §Laboratory Medicine, Division of Pathology ‡Surgical Gastroenterology #Radiology, Karolinska Institutet, Karolinska University Hospital Huddinge †Affinity Proteomics, SciLifeLab, School of Biotechnology, KTH-Royal Institute of Technology, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00002371-201705000-0000
Publisher Site
http://dx.doi.org/10.1097/CJI.0000000000000164DOI Listing
March 2017

Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decades.

Pediatr Transplant 2016 Aug 1;20(5):667-74. Epub 2016 Jun 1.

Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/petr.12723DOI Listing
August 2016

Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Human C1q Deficiency: The Karolinska Experience.

Transplantation 2016 06;100(6):1356-62

1 Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Huddinge, Sweden. 2 Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden. 3 Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden. 4 Department of Paediatrics, Karolinska University Hospital, Stockholm, Sweden. 5 Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Sachs' Children's and Youth Hospital, Stockholm, Sweden. 6 Section of Microbiology, Immunology and Glycobiology, Department of Laboratory Medicine, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000975DOI Listing
June 2016

Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.

Biol Blood Marrow Transplant 2016 Apr 29;22(4):676-681. Epub 2015 Dec 29.

Division of Therapeutic Immunology, Karolinska Institutet and Karolinska University Hospital, Huddinge, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.12.017DOI Listing
April 2016

[Important that Sweden allows new treatments on vital indication].

Authors:
Olle Ringdén

Lakartidningen 2016 Jan 18;113. Epub 2016 Jan 18.

View Article

Download full-text PDF

Source
January 2016

Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo.

Cytotherapy 2015 Dec 17;17(12):1732-45. Epub 2015 Oct 17.

Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, Sweden; Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2015.09.001DOI Listing
December 2015

Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation.

Transfusion 2015 Oct 13;55(10):2339-50. Epub 2015 May 13.

Department of Oncology and Pathology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.13143DOI Listing
October 2015

Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua.

Stem Cells Dev 2015 Oct 24;24(19):2269-79. Epub 2015 Aug 24.

1 Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet , Stockholm, Sweden .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/scd.2015.0120DOI Listing
October 2015

The relationship between oral mucositis and levels of pro-inflammatory cytokines in serum and in gingival crevicular fluid in allogeneic stem cell recipients.

Support Care Cancer 2015 Jun 30;23(6):1749-57. Epub 2014 Nov 30.

Division of Oral and Maxillofacial Surgery, Department of Dental Medicine, Karolinska Institute, Huddinge, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-014-2538-zDOI Listing
June 2015

Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2015 May 4;21(5):889-93. Epub 2015 Feb 4.

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.01.025DOI Listing
May 2015

Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome.

Authors:
Olle Ringdén

Lancet Respir Med 2015 Apr;3(4):e12

Division of Therapeutic Immunology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(15)00047-8DOI Listing
April 2015

Treatment of severe chronic graft-versus-host disease with decidual stromal cells and tracing with (111)indium radiolabeling.

Stem Cells Dev 2015 Jan;24(2):253-63

1 Division of Therapeutic Immunology, Department of Laboratory Medicine, Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet and Karolinska University Hospital , Stockholm, Sweden .

View Article

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/scd.2014.0265
Publisher Site
http://dx.doi.org/10.1089/scd.2014.0265DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291217PMC
January 2015

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

Blood 2014 Dec 16;124(26):3996-4003. Epub 2014 Oct 16.

Cancer and Inflammation Program, SAIC Frederick, Inc., Frederick National Laboratories for Cancer Research, Frederick, MD; and Ragon Institute of the Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-09-599969DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271183PMC
December 2014

GVHD prophylaxis made safe, easy, and inexpensive.

Authors:
Olle Ringdén

Blood 2014 Dec;124(25):3672-3

KAROLINSKA INSTITUTET.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-10-607879DOI Listing
December 2014

Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus Disease.

Transplantation 2014 Dec;98(12):e95-6

1 Division of Therapeutic Immunology and Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet and Karolinska University Hospital, Huddinge, Sweden. 2 Department of Infectious Diseases, Karolinska Institutet and Karolinska University Hospital, Huddinge, Sweden. 3 Department of Haematology, Karolinska Institutet and Karolinska University Hospital, Huddinge, Sweden. 4 Department of Infectious Diseases, Karlstads Hospital, Sweden 5 Address correspondence to: Olle Ringdén, M.D., Ph.D., Division of Therapeutic Immunology, Karolinska Institutet, Karolinska University Hospital Huddinge, F79, SE-141 86 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000520DOI Listing
December 2014

TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation.

J Immunother 2014 Oct;37(8):416-25

*Swedish Institute for Infectious Disease Control, SMI †Division of Therapeutic Immunology, Labmed ‡Department of Microbiology, Tumor and Cell Biology ¶Department of Pediatrics, Astrid Lindgen Barnsjukhuset §Center for allogeneic stem cell transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden ∥Department of Immunobiology and Internal Medicine, Yale University, New Haven, CT #Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000047DOI Listing
October 2014

Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia?

Transplantation 2014 Sep;98(5):569-77

1 Center for Allogeneic Stem Cell Transplantation and Division of Therapeutic Immunology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. 2 Department of Haematology, Hôpital Saint Antoine, Paris, France. 3 Department of Bone Marrow Transplantation, Essen, University Hospital, Essen, Germany. 4 Medizinische Klinik m. S. Hämatologie/Onkologie, Charité Universitätsmedizin, Berlin, Germany. 5 Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden, Germany. 6 CHU Bordeaux, Hôpital Haut-leveque, Pessac, France. 7 Division of Hematology, Oncology and Hemostasiology, University Hospital Leipzig, Leipzig, Germany. 8 Service Hématologie Greffe de Moelle, Centre Pierre et Marie Curie, Alger, Algeria. 9 Department of Hematology and BMT, Silesian Medical Academy, Katowice, Poland. 10 Department of Hematology/Oncology, Hannover Medical University, Hannover, Germany. 11 Department of Hematology - BMT, Hôpital St. Louis, Paris, France. 12 Department of Hematology/Oncology, University of Münster, Münster, Germany. 13 Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland. 14 Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom. 15 Address correspondence to: Olle Ringdén, M.D., Ph.D., Karolinska Institutet, Division of Therapeutic Immunology, Karolinska University Hospital Huddinge, F79, SE-141 86 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000102DOI Listing
September 2014

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome.

Biol Blood Marrow Transplant 2014 Sep 2;20(9):1418-25. Epub 2014 Jun 2.

Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127369PMC
September 2014

Posaconazole concentrations in human tissues after allogeneic stem cell transplantation.

Antimicrob Agents Chemother 2014 Aug 2;58(8):4941-3. Epub 2014 Jun 2.

Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.03252-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136075PMC
August 2014

In memoriam--Carl-Gustav Groth 1933-2014.

Transplantation 2014 Jul;98(2):122-3

Departments of Transplantation Surgery and Therapeutic Immunology, Karolinska Institutet, Solna, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000259DOI Listing
July 2014

Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital.

Pediatr Transplant 2014 Jun;18(4):398-404

Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden; Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/petr.12262DOI Listing
June 2014

A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors.

Clin Transplant 2013 Jul-Aug;27(4):E368-74. Epub 2013 May 22.

Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.12131DOI Listing
March 2014

Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.

Biol Blood Marrow Transplant 2014 Feb 22;20(2):264-71. Epub 2013 Nov 22.

Therapeutic Immunology Unit, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden; Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791130053
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2013.11.011DOI Listing
February 2014

Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.

Biol Blood Marrow Transplant 2014 Jan 17;20(1):135-8. Epub 2013 Oct 17.

Centre for Allogeneic Stem Cell Transplantation, Departments of Clinical Immunology and Medicine, Karolinska Hospital, Huddinge University Hospital, Huddinge, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.10.014DOI Listing
January 2014

Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment.

Acta Paediatr 2013 Nov 10;102(11):1087-94. Epub 2013 Sep 10.

Department of Clinical Science and Education, Sachs' Children's Hospital, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apa.12384DOI Listing
November 2013

Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner.

Stem Cells Dev 2013 Oct 2;22(19):2596-605. Epub 2013 Jul 2.

Division of Therapeutic Immunology, Department of Laboratory Medicine, Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet and Karolinska University Hospital , Stockholm, Sweden .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/scd.2013.0079DOI Listing
October 2013

Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease.

Stem Cells 2013 Mar;31(3):592-601

Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.1314DOI Listing
March 2013

Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients.

Int J Hematol 2012 Dec 11;96(6):822-4. Epub 2012 Nov 11.

Department of Therapeutic Immunology, Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Huddinge, SE-141 86, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12185-012-1218-3
Publisher Site
http://dx.doi.org/10.1007/s12185-012-1218-3DOI Listing
December 2012

Is graft-versus-leukemia more effective using reduced-intensity conditioning compared with myeloablative conditioning?

Biol Blood Marrow Transplant 2012 Nov 27;18(11):1615-7. Epub 2012 Sep 27.

Division of Therapeutic Immunology and Center for Allogeneic Stem Cell Transplantation, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387911200371
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2012.09.006DOI Listing
November 2012

Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation.

Eur J Haematol 2012 Sep;89(3):220-7

Division of Respiratory Medicine and Allergology, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Huddinge, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2012.01824.xDOI Listing
September 2012

Are therapeutic human mesenchymal stromal cells compatible with human blood?

Stem Cells 2012 Jul;30(7):1565-74

Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.1111DOI Listing
July 2012

Mesenchymal stem cells inhibit thymic reconstitution after allogeneic cord blood transplantation.

Stem Cells Dev 2012 Jun 12;21(9):1409-17. Epub 2011 Oct 12.

Clinical Immunology Unit, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/scd.2011.0310DOI Listing
June 2012

Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy.

Biol Blood Marrow Transplant 2012 Apr 4;18(4):557-64. Epub 2011 Aug 4.

Haematology Centre, Department of Clinical Immunology, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.07.023DOI Listing
April 2012

Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation.

Br J Haematol 2012 Apr 2;157(2):220-9. Epub 2012 Feb 2.

Centre for Allogeneic Stem Cell Transplantation and Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2012.09034.xDOI Listing
April 2012

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Lancet Oncol 2012 Apr 15;13(4):366-74. Epub 2012 Feb 15.

Unit of Molecular and Functional Immunogenetics, Division of Regenerative Medicine, Stem Cells and Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico H San Raffaele, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70004-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813000PMC
April 2012

Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses.

PLoS One 2011 1;6(7):e21703. Epub 2011 Jul 1.

Department of Laboratory Medicine, Clinical Immunology and Transfusion Medicine, Karolinska Institutet and Hematology Center at Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0021703PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128611PMC
November 2011

Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation.

Transpl Immunol 2011 Sep 21;25(2-3):153-8. Epub 2011 Jun 21.

Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet at Karolinska University Hospital, Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trim.2011.06.001DOI Listing
September 2011

Xerostomia in children and adolescents after stem cell transplantation conditioned with total body irradiation or busulfan.

Oral Oncol 2011 Sep 23;47(9):915-9. Epub 2011 Jul 23.

Department of Dental Medicine, Division of Orthodontics and Pediatric Dentistry, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2011.06.509DOI Listing
September 2011

Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure.

Clin Transplant 2011 Jan-Feb;25(1):E68-76. Epub 2010 Oct 14.

Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-0012.2010.01324.xDOI Listing
June 2011

N-acetyl-L-cysteine increases acute graft-versus-host disease and promotes T-cell-mediated immunity in vitro.

Eur J Immunol 2011 Apr 21;41(4):1143-53. Epub 2011 Feb 21.

Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201040589DOI Listing
April 2011